Skip to main content

Remote Job Finders (RJF)

On steadier ground, pharma heads into Q1 earnings with deals top of mind

During the pharma earnings season, which begins on Tuesday, Novo Nordisk will report the first revenue numbers from an oral GLP-1 medicine, while other companies are expected to address the FDA, drug pricing and Trump’s new tariffs.

USP adds Tamiflu, Trulicity to vulnerable list as upstream analysis reshapes supply concerns

Almost half of the top 100 medicines vulnerable to supply disruptions in the U.S. have at least one key starting material with a single source country, according to a new report from United States Pharmacopeia.
Scroll to top